.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Colorcon
UBS
US Army
Merck
Healthtrust
Teva
Queensland Health
Medtronic
Julphar

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022578

« Back to Dashboard
NDA 022578 describes ZYRTEC ALLERGY, which is a drug marketed by J And J Consumer Inc and is included in two NDAs. It is available from four suppliers. Additional details are available on the ZYRTEC ALLERGY profile page.

The generic ingredient in ZYRTEC ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and sixty suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

Summary for NDA: 022578

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022578

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZYRTEC ALLERGY
cetirizine hydrochloride
 TABLET, ORALLY DISINTEGRATING;ORAL 022578 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-778 50580-778-24 4 BLISTER PACK in 1 CARTON (50580-778-24) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
ZYRTEC ALLERGY
cetirizine hydrochloride
 TABLET, ORALLY DISINTEGRATING;ORAL 022578 NDA Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 50580-782 50580-782-01 2 CARTON in 1 PACKAGE (50580-782-01) > 4 BLISTER PACK in 1 CARTON > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, ORALLY DISINTEGRATING;ORALStrength10MG
Approval Date:Sep 3, 2010TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
McKinsey
Baxter
Chubb
Colorcon
US Army
Deloitte
Citi
UBS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot